
Churchill documents reveal D-Day landings boosted by import of ‘wonder drug' from America
Despite its discovery in London in 1928 by Sir Alexander Fleming, large-scale production of the antibiotic penicillin had struggled to take hold in Britain.
Attempts to produce substantial quantities of medicine from the bacteria-killing mould had not been achieved by the start of the Second World War.
Then prime minister Sir Winston Churchill became increasingly frustrated that Britain had not been able to produce enough penicillin in the preparations for the Normandy landings in 1944.
Official papers released by the National Archive – containing handwritten notes by Sir Winston – highlight efforts to boost quantities of the antibiotic, with Britain eventually forced to import it from America.
The documents were released ahead of the 81st anniversary of D-Day, the Allied invasion of Normandy on June 6, 1944.
In one report on February 19, after the issue had been raised in the House of Commons, Sir Winston scrawled in red ink on a Ministry of Supply report noting the Americans were producing greater quantities: 'I am sorry we can't produce more.'
On another paper, he complained: 'Your report on penicillin showing that we are only to get about one tenth of the expected output this year, is very disappointing.'
Elsewhere in the same file he instructs: 'Let me have proposals for a more abundant supply from Great Britain.'
With preparations for D-Day ramped up, efforts to deliver enough American-made penicillin for frontline military personnel soon became a matter of urgency.
Decisions needed to be made on the quantities of antibiotic imported, how much to administer to individual patients, and how to get medical staff trained in time.
Most British doctors did not know how to issue penicillin – until this point, doctors had nothing available to treat infections like pneumonia and many people died of blood poisoning after minor injuries because no drug existed that could cure them.
Early in January 1944, Prof FR Fraser, the Ministry of Health's adviser on the organisation of wartime hospitals, wrote that 50,000-100,000 wounded could be expected from the Second Front.
He proposed the Emergency Medical Services might need as many as five billion units of penicillin per month for this.
Further documents show discussions on whether the antibiotic should be supplied as calcium or sodium salts, or in tablet form.
Ultimately, it was agreed powdered calcium salts would be issued for superficial wounds and sodium salts for use in deep wounds.
On May 24 1944, less than a fortnight before D-Day, Prof Fraser reported: 'Sufficient supplies of penicillin are now available for the treatment of battle casualties in EMS hospitals, but not for ordinary civilian patients.'
Plans were made for casualties from the frontline in France to be brought back to coastal hospitals in Britain for treatment.
A week before D-Day, on May 30 1944, hospitals were instructed to treat battlefield patients en route: 'In an endeavour to prevent the development of gas gangrene and sepsis in wounds the War Office have arranged for the treatment of selected cases by penicillin to be commenced as soon after injury as possible.'
Injections of penicillin were to be given to them at intervals of not more than five hours and patients would be wearing a yellow label with the letters 'PEN'. The time and size of penicillin doses should be written on it, they were told.
Dr Jessamy Carlson, modern records specialist at the National Archives, said: 'File MH 76/184 gives a glimpse into the extraordinary levels of preparation undertaken in advance of the D-Day landings.
'Only six weeks before, penicillin is just reaching our shores in quantities which will allow it to play a major role in improving the outcomes for service personnel wounded in action.'
As Allied forces made inroads into Europe, restrictions on the use of penicillin for civilians began to relax, but only in special cases.
In July 1944, Ronald Christie, professor of medicine, wrote to Prof Fraser to tell him: 'The War Office approves of American penicillin being used for medical conditions in service patients and for air raid casualties among civilians.'
On the home front, demand for the new 'wonder' drug began to increase, according the National Archives.
It was decided that penicillin for civilians should only be supplied to larger hospitals where the staff had been properly trained to administer it.
Only in 1946 did it become fully available for the general public.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Daily Mail
an hour ago
- Daily Mail
I was cured of one of the deadliest forms of cancer after trialling a new drug... my brain cancer is gone
A father who suffered with the world's deadliest form of brain cancer has been cleared after he underwent an experimental treatment. Ben Trotman, 43, who was diagnosed with glioblastoma in October 2022, is now showing no signs of the disease after being administered an immunotherapy drug in a world first two years ago. Most patients with the aggressive form of brain cancer typically die within 12-to-18 months. Consultant medical oncologist, Dr Paul Mulholland, who is leading the new trial and treated Mr Trotman, said: 'It is very unusual to have a clear scan with glioblastoma, especially when he didn't have the follow-up surgery that had been planned to remove all of the tumour that was initially visible on scans. 'We hope that the immunotherapy and follow-up treatment Ben has had will hold his tumour at bay – and it has so far, which we are delighted to see.' Mr Trotman married his wife Emily two months after the immunotherapy treatment in 2023, and in April, his daughter Mabel was born. The father-of-one said: 'Getting this diagnosis was the most traumatic experience. We were grappling with the fact that Ben had gone from being apparently perfectly healthy to having months to live. 'Had we not met Dr Mulholland, that would have been it for us. We felt we had a lucky break in an otherwise devastating situation.' Ben Trotman, 43, who was diagnosed with glioblastoma in October 2022, is now showing no signs of the disease after being administered an immunotherapy drug in a world first two years ago Mr Trotman went on to have the current standard treatment of radiotherapy and chemotherapy. He also undergoes quarterly cans, which continue to return clear. 'We obviously don't know what the future holds but having had the immunotherapy treatment and getting these encouraging scan results has given Emily and I a bit of hope,' he said. 'We are focused on rebuilding the life we thought we had lost and enjoying being parents'. The trial, from University College London Hospital's National Hospital for Neurology and Neurosurgery, follows a previous one on the same drug which closed because of lack of recruitment. But Dame Siobhain McDonagh MP lead a fundraising campaign to raise more than £1million to cover the costs of the new trials after her sister, Baroness McDonagh, died from glioblastoma in 2023. Dame Siobhain said: 'My beloved sister Margaret was appalled to discover that there had been no advances in brain cancer treatment for decades when she was diagnosed with glioblastoma. 'Changing this was Margaret's final campaign and one that I have continued in her memory. 'I am so grateful to the many people who knew and respected Margaret who have come together and helped to raise funds and campaign for this new trial that we are calling Margaret's Trial.' Dr Paul Mulholland said: 'When I met Margaret she said to me 'what can I do to support you to cure this disease?'. 'I am incredibly grateful to her and to Siobhain whose campaigning and fundraising in her sister's memory has led to this new clinical trial opening for patients with this most aggressive form of brain cancer that has such a poor prognosis, with most patients surviving just nine months after diagnosis. 'The crucial element of this trial is that patients will have their immune system boosted by the drug before they have any other treatment, when they are fit and well enough to tolerate the immunotherapy. 'We're taking everything we have learned from previous trials into this new study and we are already planning follow-on trials. 'My aim is to find a cure for glioblastoma.' The National Brain Appeal is currently funding two posts in support of Dr Mulholland's research. Treatment will take place at the NIHR UCLH's Clinical Research Facility and at the National Hospital for Neurology and Neurosurgery.


Daily Mail
an hour ago
- Daily Mail
Diet that sheds weight fast by eating MORE: This easy plan was made to help cancer patients - then doctors realised its amazing benefits. JANE ALEXANDER tried it and couldn't believe how much she lost...
At the age of 65, I have reached crunch point. I'm sick to the back teeth of weird diets and I'm seriously fed up with feeling hungry. I'm also really hacked off at still being fat. It's not just how I look – my GP has told me I really need to lose my stores of visceral fat (the pernicious fat around the organs in the abdomen that is so bad for our health).


The Independent
2 hours ago
- The Independent
Almost half of people do not think 10-year plan will boost GP access
Almost half of people think that Government plans to improve the health of the nation will have no difference, or make it harder to get a GP appointment, according to a survey. More than four in 10 also believe the 10-year plan will make no difference or will not improve waiting times in A&E. However, there is huge support for some of the ideas included in the blueprint, with the overwhelming majority backing the creation of neighbourhood health centres, the expansion of the NHS app and more mental health support in schools and colleges. The 10-year health plan was unveiled by Prime Minister Sir Keir Starmer earlier this month, and set out a series of shifts to bring care much closer to people's homes, reducing the reliance on hospitals and A&E. Key reforms include an enhanced NHS app, giving patients more control over their care, new neighbourhood health centres open six days a week and at least 12 hours a day, and new laws on food and alcohol to prevent ill health. A survey of 1,023 adults in Britain, conducted by Ipsos for the PA news agency, asked people how they think the plan will impact access to healthcare, such as getting a GP appointment, A&E waiting times and waiting times for routine hospital treatment. Some 35% said the plan will have no impact on getting a GP appointment, while 14% believe it will make things harder. This compares with the 29% of people who said they think it will make getting an appointment easier. More than a third (37%) said it will make no difference to waiting times in emergency departments, while almost one in 10 (9%), said they believe it could worsen waiting times, compared with 30% who said it will improve them. Meanwhile, 31% said the plan will have no impact on waiting times for hospital treatment, 11% believe the plan will worsen waiting times and 34% said they think the measures will help. However, a number of proposals outlined in the plan were strongly backed by the public. Some 84% said they supported the creation of a single patient record, while 78% backed the creation of neighbourhood health centres, 73% support the expansion of the NHS app and 72% are in favour of more mental health support in schools and colleges. However, more than a quarter (27%) of people do not support making hospitals fully AI enabled, compared with 44% who would back the move. Almost one in five (18%) said they would not support so-called 'patient power payments', which would allow patients to hold back some of the payment for their care if they are not satisfied, while 42% would support the measure. Some proposals aimed at helping people to lead healthier lives were also strongly supported. A ban on the sale of high-caffeine energy drinks was backed by 78% of people, while 69% back plans to restrict junk food advertising. However, almost one in five (18%) tended to disagree with measures that could see alcoholic drinks labelled with nutritional information, although 57% backed the move. One in four people think the measures included in the plan will make no difference to patients, the poll found. Almost one in 10 (9%) said they think the changes will make things worse, while 35% believe it will improve the health service. A similar proportion, 23%, said the 10-year health plan will make no difference to NHS staff, while 13% said it could make things worse and 33% believe it will have a positive effect. A Department of Health and Social Care spokesperson said: 'We're getting on with the job of delivering for patients, with NHS waiting lists falling by 260,000 since July 2024, delivering more than 4.6 million additional appointments since the general election and recruiting over 1,900 extra GPs to fix the front door of the NHS. 'Backed by an additional £29 billion, our 10-year health plan will seize the opportunities provided by new technology, medicines and innovation to deliver better care for all patients, no matter where they live or how much they earn, and better value for taxpayers. 'It is no surprise the plan is popular with patients, it was the result of the biggest conversation with staff, patients and the public since the formation of the NHS, with more than a quarter of a million contributions.'